Båvenholm PN - Search Results

1

Postprandial hyperglycaemia and vascular damage--the benefits of acarbose.

Båvenholm PN, Efendic S. Båvenholm PN, et al. Diab Vasc Dis Res. 2006 Sep;3(2):72-9. doi: 10.3132/dvdr.2006.017. Diab Vasc Dis Res. 2006. PMID: 17058626 Free article. Review.

2

Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes.

Wagner H, Degerblad M, Thorell A, Nygren J, Ståhle A, Kuhl J, Brismar TB, Ohrvik J, Efendic S, Båvenholm PN. Wagner H, et al. Among authors: bavenholm pn. Diabetes Care. 2006 Jul;29(7):1471-7. doi: 10.2337/dc05-2513. Diabetes Care. 2006. PMID: 16801564 Clinical Trial.

3

Insulin sensitivity of suppression of endogenous glucose production is the single most important determinant of glucose tolerance.

Båvenholm PN, Pigon J, Ostenson CG, Efendic S. Båvenholm PN, et al. Diabetes. 2001 Jun;50(6):1449-54. doi: 10.2337/diabetes.50.6.1449. Diabetes. 2001. PMID: 11375347

4

Insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation.

Båvenholm PN, Kuhl J, Pigon J, Saha AK, Ruderman NB, Efendic S. Båvenholm PN, et al. J Clin Endocrinol Metab. 2003 Jan;88(1):82-7. doi: 10.1210/jc.2002-020330. J Clin Endocrinol Metab. 2003. PMID: 12519834

5

Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.

Ahrén B, Simonsson E, Larsson H, Landin-Olsson M, Torgeirsson H, Jansson PA, Sandqvist M, Båvenholm P, Efendic S, Eriksson JW, Dickinson S, Holmes D. Ahrén B, et al. Diabetes Care. 2002 May;25(5):869-75. doi: 10.2337/diacare.25.5.869. Diabetes Care. 2002. PMID: 11978683 Clinical Trial.

6

[Exercise is an effective weapon in the fight against type 2 diabetes].

Ostenson CG, Båvenholm P, Efendic S. Ostenson CG, et al. Lakartidningen. 2004 Dec 2;101(49):4011-2, 4014-5. Lakartidningen. 2004. PMID: 15633340 Review. Swedish. No abstract available.

7

Early microvascular dysfunction in healthy normal-weight males with heredity for type 2 diabetes.

Jörneskog G, Kalani M, Kuhl J, Båvenholm P, Katz A, Allerstrand G, Alvarsson M, Efendic S, Ostenson CG, Pernow J, Wahren J, Brismar K. Jörneskog G, et al. Diabetes Care. 2005 Jun;28(6):1495-7. doi: 10.2337/diacare.28.6.1495. Diabetes Care. 2005. PMID: 15920077 No abstract available.

8

Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance.

Shemyakin A, Böhm F, Wagner H, Efendic S, Båvenholm P, Pernow J. Shemyakin A, et al. J Cardiovasc Pharmacol. 2006 Mar;47(3):385-90. doi: 10.1097/01.fjc.0000210070.47205.16. J Cardiovasc Pharmacol. 2006. PMID: 16633080

9

Fatty acid oxidation and the regulation of malonyl-CoA in human muscle.

Båvenholm PN, Pigon J, Saha AK, Ruderman NB, Efendic S. Båvenholm PN, et al. Diabetes. 2000 Jul;49(7):1078-83. doi: 10.2337/diabetes.49.7.1078. Diabetes. 2000. PMID: 10909961

10

Characterisation of subjects with early abnormalities of glucose tolerance in the Stockholm Diabetes Prevention Programme: the impact of sex and type 2 diabetes heredity.

Kuhl J, Hilding A, Ostenson CG, Grill V, Efendic S, Båvenholm P. Kuhl J, et al. Diabetologia. 2005 Jan;48(1):35-40. doi: 10.1007/s00125-004-1614-1. Epub 2004 Dec 24. Diabetologia. 2005. PMID: 15619073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters